DHCDiversified Healthcare TrustReal Estate · REIT - Healthcare Facilitiesas of 2026-09-16
Horizon

Issued 2026-09-16 at $7.94 · now $7.94 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, DHC has typically landed between $6.02 and $10.57 — a range of −24.2% to +33.1% from the issuance price $7.94.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,003 overlapping 1 month windows · 2006-09-262026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($7.94) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where DHC has typically landed a month from the 2026-09-16 close of $7.94 — the range is history, not a prediction.

$6.02worst · -24.2%$10.57best · +33.1%
  • now $7.94 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $8.04 (+1.3%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $7.09$8.99
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $6.02$10.57
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,003 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2020-02-18−72.6%−72.6%+1.9%
2020-02-19−69.4%−72.4%+2.7%
2020-02-14−68.5%−68.5%+2.4%
3 best
2023-05-12+253.1%−0.2%+253.1%
2023-05-15+249.0%+0.0%+253.7%
2023-05-11+238.8%−0.6%+238.8%

5,003 overlapping windows · 2006-09-262026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
65%
+2.7%
n=20
Feb
45%
+1.0%
n=20
Mar
55%
+0.6%
n=20
Apr
55%
−3.1%
n=20
May
60%
+4.5%
n=20
Jun
60%
+5.8%
n=20
Jul
50%
+0.2%
n=20
Aug
60%
+1.9%
n=20
Sep
45%
−1.9%
n=20
Oct
60%
+1.7%
n=20
Nov
30%
−4.9%
n=20
Dec
60%
+3.9%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$10$3↑ buys↓ sales
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

1 award / exercise / gift record — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2025-09-16Brown Matthew C.officerWithheld for tax9,711113,954Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.